In Cancer Resistance Battle, Drugmakers' Arsenal Contains Combo Drugs, Common Biomarkers, ctDNA
Premium
Cancer patients invariably develop resistance to targeted drugs, so drugmakers develop strategies to combat it before first-generation therapies hit the market.
Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.
This small branch played a big role in advancing evidence-based genetic testing, and its loss diminishes US leadership in public health, say supporters.
FD Foundation Spinout Tikun Therapeutics Charges Ahead Studying Therapies for Familial Dysautonomia
Premium
The New York-based public benefit corporation is advancing three drug candidates for the extremely rare condition.
The tool analyzes results from standard tests of organ function, tumor burden, and inflammation to predict whether lymphoma patients will respond to treatment.
Vertex Appeals Ruling That Fertility Support for Casgevy Patients Would Violate Kickback Laws
A federal district court had ruled in favor of HHS, restricting Vertex's ability to provide fertility preservation services to Medicaid patients.